Physician profile
Jackson Flanigan
NPI 1760564793
$32,552.19
in general payments reported to CMS, 2019-2025
23 companies · $276 in 2025
The $276 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $558 · 2020: $1,143 · 2021: $3,173 · 2022: $21K · 2023: $5,678 · 2024: $380 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $1,434 · Food and Beverage: $899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $1,434.33 |
| Food and Beverage | $899.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $16,248.40 | 2022-2024 | Davinci Xi, Da Vinci Surgical System |
| Angiodynamics, INC. | $12,555.56 | 2021-2022 | |
| Cardiovascular Systems INC. | $756.69 | 2019-2021 | |
| Philips North America LLC | $613.69 | 2020-2024 | (Az7) Lasers, (Br5) Peripheral Ivus |
| Cook Medical LLC | $415.78 | 2019-2022 | |
| Abbott Laboratories | $404.45 | 2020-2025 | Perclose Prostyle, Esprit, Diamondback Peripheral |
| Endologix LLC | $325.32 | 2019-2020 | |
| Veryan Medical Incorporated | $285.49 | 2021 | |
| Surmodics, INC. | $154.68 | 2022 | |
| Medtronic, INC. | $117.82 | 2022-2025 | Progrip, Venaseal |
| Organogenesis INC. | $110.96 | 2022-2025 | Via Matrix, Puraply |
| Tela Bio, INC. | $104.25 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Astrazeneca Pharmaceuticals Lp | $94.71 | 2021-2022 | |
| Lemaitre Vascular, INC. | $75.06 | 2020-2021 | |
| Davol INC. | $60.82 | 2019-2025 | Phasix Mesh |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $48.60 | 2021 | |
| Cordis US Corp. | $44.82 | 2024 | Infiniti |
| Stryker Corporation | $37.24 | 2020 | |
| Convatec INC. | $31.78 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.82 | 2024 | Glassia |
| Cardinal Health 200 LLC | $16.33 | 2020 | |
| Becton, Dickinson and Company | $14.87 | 2024 | Venclose Maven Catheter |
| Pacira Pharmaceuticals Incorporated | $13.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jackson Flanigan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.